Related Experiment Videos
[Ocular pulse amplitude in ocular hypertension and open-angle glaucoma]
K G Schmidt1, A von Rückmann, T W Mittag
1Department of Ophthalmology, Mt. Sinai School of Medicine, New York, NY, USA.
Summary
Ocular hypertensive patients exhibit increased choroidal perfusion, potentially protecting against glaucoma. Antiglaucoma drugs lowered intraocular pressure but did not enhance ocular pulse amplitude or choroidal blood flow.
Area of Science:
- Ophthalmology
- Glaucoma Research
- Ocular Circulation
Background:
- Primary open-angle glaucoma (POAG) is a leading cause of irreversible blindness.
- Intraocular pressure (IOP) is a major risk factor for POAG progression.
- Choroidal perfusion plays a crucial role in optic nerve health and may influence glaucoma development.
Purpose of the Study:
- To investigate choroidal perfusion in patients with high-pressure (HPG) and normal-pressure (NPG) open-angle glaucoma.
- To compare choroidal perfusion in glaucoma patients with ocular hypertensive (OHT) volunteers.
- To assess the effect of topical antiglaucomatous drugs on choroidal perfusion and IOP.
Main Methods:
- Ocular pulse amplitude (OPA) and IOP measurements were taken before and after drug application.
- Participants included HPG, NPG, OHT volunteers, and age-matched healthy controls.
- Topical antiglaucomatous medications were administered to assess their impact on ocular hemodynamics.
Main Results:
- OHT subjects showed significantly increased IOP and OPA compared to healthy controls.
- HPG patients had elevated IOP but unchanged OPA, while NPG patients had normal IOP and reduced OPA.
- Antiglaucomatous drugs effectively reduced IOP but did not alter OPA or choroidal perfusion.
Conclusions:
- Ocular hypertensive individuals exhibit enhanced choroidal perfusion, possibly a compensatory mechanism against glaucomatous damage.
- Reduced OPA in normal-pressure glaucoma suggests impaired ocular blood flow regulation.
- Current topical antiglaucomatous drugs lower IOP but do not improve choroidal blood flow, highlighting a potential area for therapeutic development.